Breaking News - The Fly

Open Search

VTGN

Vistagen

$

()

Vistagen starts PALISADE-4 Phase 3 study of fasedienol for SAD treatment

VTGN

9/23/2024 - 08:36am

Vistagen reports Q1 EPS (35c), two estimates (40c)

VTGN

8/13/2024 - 16:22pm

Vistagen receives multiple new patents related to use of PH80

VTGN

7/9/2024 - 08:38am

Biotech Alert: Searches spiking for these stocks today

HOTH , DERM , APLT

…

6/13/2024 - 10:53am

Fly Intel: After-Hours Movers

BMR , ORCL , CASY

…

6/11/2024 - 18:24pm

Vistagen reports FY24 EPS ($1.52) vs. ($8.51) last year

VTGN

6/11/2024 - 16:21pm

Vistagen says PH15 shows statistically significant improvement in reaction time

VTGN

4/25/2024 - 08:39am

Biotech Alert: Searches spiking for these stocks today

EIGR , GRTX , ETNB

…

4/3/2024 - 10:52am

Vistagen initiates Phase 3 fasedienol trial for SAD treatment

VTGN

4/1/2024 - 08:47am

Vistagen files $350M mixed securities shelf

VTGN

2/13/2024 - 16:54pm

Vistagen reports Q3 EPS (22c), consensus (30c)

VTGN

2/13/2024 - 16:23pm

Vistagen plans strategic collaborations and commercializion for AV-101

VTGN

12/27/2023 - 08:42am

Vistagen announces EPO notice of intention to grant patent to AV-101 for pain

VTGN

12/27/2023 - 08:37am

Vistagen announces EPO notice of intention to grant patent to AV-101 for pain

VTGN

12/27/2023 - 08:36am

Vistagen upgraded to Buy from Hold at Jefferies

VTGN

12/7/2023 - 05:11am